CVS Health Debt to Equity Ratio 2010-2024 | CVS
Current and historical debt to equity ratio values for CVS Health (CVS) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. CVS Health debt/equity for the three months ending June 30, 2024 was 0.83.
| CVS Health Debt/Equity Ratio Historical Data |
| Date |
Long Term Debt |
Shareholder's Equity |
Debt to Equity Ratio |
| 2024-06-30 |
$177.37B |
$75.11B |
2.36 |
| 2024-03-31 |
$175.59B |
$74.15B |
2.37 |
| 2023-12-31 |
$173.09B |
$76.64B |
2.26 |
| 2023-09-30 |
$176.80B |
$74.51B |
2.37 |
| 2023-06-30 |
$177.07B |
$73.00B |
2.43 |
| 2023-03-31 |
$167.75B |
$71.58B |
2.34 |
| 2022-12-31 |
$156.51B |
$71.77B |
2.18 |
| 2022-09-30 |
$160.20B |
$71.01B |
2.26 |
| 2022-06-30 |
$154.77B |
$75.51B |
2.05 |
| 2022-03-31 |
$158.73B |
$74.14B |
2.14 |
| 2021-12-31 |
$157.62B |
$75.38B |
2.09 |
| 2021-09-30 |
$160.27B |
$74.62B |
2.15 |
| 2021-06-30 |
$157.60B |
$73.57B |
2.14 |
| 2021-03-31 |
$158.44B |
$71.16B |
2.23 |
| 2020-12-31 |
$161.01B |
$69.70B |
2.31 |
| 2020-09-30 |
$163.79B |
$69.11B |
2.37 |
| 2020-06-30 |
$167.14B |
$68.36B |
2.45 |
| 2020-03-31 |
$165.17B |
$65.47B |
2.52 |
| 2019-12-31 |
$158.28B |
$64.17B |
2.47 |
| 2019-09-30 |
$157.18B |
$62.93B |
2.50 |
| 2019-06-30 |
$157.31B |
$61.60B |
2.55 |
| 2019-03-31 |
$159.76B |
$60.01B |
2.66 |
| 2018-12-31 |
$137.91B |
$58.54B |
2.36 |
| 2018-09-30 |
$94.88B |
$36.62B |
2.59 |
| 2018-06-30 |
$97.68B |
$35.61B |
2.74 |
| 2018-03-31 |
$96.46B |
$38.68B |
2.49 |
| 2017-12-31 |
$57.44B |
$37.70B |
1.52 |
| 2017-09-30 |
$57.99B |
$34.87B |
1.66 |
| 2017-06-30 |
$58.38B |
$34.15B |
1.71 |
| 2017-03-31 |
$58.83B |
$33.84B |
1.74 |
| 2016-12-31 |
$57.63B |
$36.83B |
1.57 |
| 2016-09-30 |
$58.20B |
$35.95B |
1.62 |
| 2016-06-30 |
$57.98B |
$34.77B |
1.67 |
| 2016-03-31 |
$56.60B |
$36.03B |
1.57 |
| 2015-12-31 |
$55.23B |
$37.20B |
1.49 |
| 2015-09-30 |
$55.18B |
$37.18B |
1.48 |
| 2015-06-30 |
$37.54B |
$37.13B |
1.01 |
| 2015-03-31 |
$36.94B |
$37.00B |
1.00 |
| 2014-12-31 |
$36.22B |
$37.96B |
0.95 |
| 2014-09-30 |
$35.47B |
$38.11B |
0.93 |
| 2014-06-30 |
$34.46B |
$38.13B |
0.90 |
| 2014-03-31 |
$34.61B |
$38.21B |
0.91 |
| 2013-12-31 |
$33.59B |
$37.94B |
0.89 |
| 2013-09-30 |
$29.27B |
$38.53B |
0.76 |
| 2013-06-30 |
$27.38B |
$38.91B |
0.70 |
| 2013-03-31 |
$27.86B |
$38.21B |
0.73 |
| 2012-12-31 |
$28.57B |
$37.65B |
0.76 |
| 2012-09-30 |
$27.88B |
$36.92B |
0.76 |
| 2012-06-30 |
$27.68B |
$37.91B |
0.73 |
| 2012-03-31 |
$27.95B |
$38.05B |
0.74 |
| 2011-12-31 |
$26.49B |
$38.05B |
0.70 |
| 2011-09-30 |
$27.76B |
$37.49B |
0.74 |
| 2011-06-30 |
$27.24B |
$38.24B |
0.71 |
| 2011-03-31 |
$24.91B |
$37.92B |
0.66 |
| 2010-12-31 |
$24.47B |
$37.70B |
0.65 |
| 2010-09-30 |
$25.08B |
$36.64B |
0.68 |
| 2010-06-30 |
$25.65B |
$35.87B |
0.72 |
| 2010-03-31 |
$25.59B |
$35.69B |
0.72 |
| 2009-12-31 |
$25.87B |
$35.77B |
0.72 |
| 2009-09-30 |
$26.20B |
$35.68B |
0.74 |
| 2009-06-30 |
$24.88B |
$36.15B |
0.69 |
| 2009-03-31 |
$25.37B |
$35.29B |
0.72 |
| Sector |
Industry |
Market Cap |
Revenue |
| Retail/Wholesale |
Retail - Drug Stores |
$70.208B |
$357.776B |
|
CVS Health Corporation is a pharmacy innovation company. Its offerings include pharmacy benefit management services, mail order, retail and specialty pharmacy, disease management programs, and retail clinics. The Company serves employers, insurance companies, unions, government employee groups, managed care organizations and other sponsors of health benefit plans, and individuals under the CVS Caremark Pharmacy Services, Caremark, CVS Caremark, CarePlus CVS/pharmacy, RxAmerica, Accordant, SilverScript, and Novologix names. CVS Health Corporation, formerly known as CVS Caremark Corporation, is headquartered in Woonsocket, Rhode Island.
|
